Results 291 to 300 of about 112,075 (306)

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

Nature, 2019
Yi Duan, Cristina Llorente, Sonja Lang
exaly  

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

Nature Reviews Drug Discovery, 2016
Giovanni Musso, Roberto Gambino
exaly  

Alcoholic liver disease

Nature Reviews Disease Primers, 2018
Helmut Karl Seitz, Ramon Bataller, Helena Cortez-Pinto   +2 more
exaly  

Management of alcoholic hepatitis

Journal of Hepatology, 2012
Philippe, Mathurin, Michael R, Lucey
openaire   +2 more sources

Alcoholic liver disease: pathogenesis and new targets for therapy

Nature Reviews Gastroenterology and Hepatology, 2011
Jose Altamirano, Ramon Bataller
exaly  

Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease

Nature Reviews Nephrology, 2017
Giovanni Targher, Christopher D Byrne
exaly  

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Lancet, The, 2015
Brent A Neuschwander-Tetri, Arun J Sanyal, Joel E Lavine   +2 more
exaly  

Liver transplantation for alcoholic liver disease

Nature Reviews Gastroenterology and Hepatology, 2014
Michael R Lucey
exaly  

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Lancet, The, 2019
Zobair M Younossi, Mary E Rinella, Quentin M Anstee, Frcp   +2 more
exaly  

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

Gut, 2017
Quentin M Anstee, Frcp, Herbert Tilg, Giovanni Targher   +2 more
exaly